Oral selumetinib (AstraZeneca) reduces tumor volume in children with inoperable plexiform neurofibroma, benign tumors of peripheral nerves related to neurofibromatosis type 1 (NF1), with acceptable ...

Benign tumors, neurofibromas can arise anywhere along a nerve fiber and usually involve nerves in or near the skin. The tumors are populated by Schwann cells, fibroblasts, mast cells, and vascular ...

McKinnon Galloway was diagnosed with neurofibromatosis type 2, a rare disorder that makes tumors grow around her nerves ...

You walk through life, seeing what's on the surface. But beneath it, a battle rages, unseen by most. A relentless war fought ...

Cred: SpringWorks Therapeutics. Mirdametinib is an inhibitor of mitogen-activated protein kinase kinases 1 and 2. Gomekli is the first medication approved for both adult and pediatric patients with ...

CHICAGO -- Selumetinib (Koselugo) significantly improved response rates in adults with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas, the phase III KOMET trial ...

Neurofibromatosis type 1 (NF1) is a rare genetic condition that affects how certain nerve cells grow and develop. Children with NF1 can have small growths on or under the skin called neurofibromas.

Figure 1 (A) Clinical picture, (B) Usg showing intramuscular heterogenous lesion arising from sciatic nerve, (C) MRI showing heterogeneously isointense mass measuring 12.8 × 6.6 × 3.8 cm with features ...

Dr. Robert (Bob) Kesterson is Professor of Cancer Precision Medicine and Director of the Genetically Engineered Models, or GEMS, core facility at the Pennington Biomedical Research Center.